Business Wire

Vivasure Medical Announces Series D Financing to Advance Portfolio of PerQseal Vessel Closure Devices

GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ® (“Vivasure” or the “Company”), a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced the closing ...
Business Wire

Vivasure Announces Positive Results of PATCH IDE Pivotal Study Indicating Safety and Efficacy of PerQseal ® Large Hole Closure Device

GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced initial positive results from its U.S. IDE ...
Medscape

Different Strengths for LAA Closure Devices?

On the basis of outcomes, there was no clear winner from a trial that directly compared two modern devices used in patients undergoing percutaneous left atrial appendage (LAA) closure. But the devices ...
TCTMD

TCT 615: Decommissioning Of Left Ventricular Assist Device by Percutaneous Closure of Outflow Graft Using VSD occluder device and Amplatzer Vascular Plug

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
BioWorld

Merged firms seek lock down of percutaneous wound market with suture holding device

Ra Medical Systems Inc. launched a simple device that holds sutures more securely in place for closure of percutaneous wound sites during cardiac electrophysiology, structural heart and vascular ...
TCTMD

TCT 691: Percutaneous Closure of Left Atrial Appendage With Suture Dehiscence Using ASD Closure Device Guided by a Novel Live 3D-ICE Probe

Debate: My Patient has a Blood Pressure of 150/90 Despite 2 Maximally Dosed Medications – Time for a Third Medication! Receive the the latest news, research, and presentations from major meetings ...